6 terminated. 6 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Terminated 6 |
| Phase 3 | 1 | Terminated 1 |
Follow Cerebral Infarction: new trials by email Literature Review of Cerebral Infarction trials Research Report on Cerebral Infarction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Investigation of Neural Stem Cells in Ischemic Stroke CTX0E03 Drug Product and delivery device, Placebo - Ischemic Stroke, Chronic Stroke | Phase 2 | Terminated | ReNeuron Limited | 15 | 2018-08-31 | 2021-08-13 |
| A Study to Evaluate the Safety and Efficacy of Basmisanil in Adults With Severe Motor Impairment Following an Ischemic Stroke Basmisanil, Placebo - Stroke | Phase 2 | Terminated | Hoffmann-La Roche | 5 | 2017-02-20 | 2019-01-02 |
| The Efficacy and Safety Study of ALbumin Therapy in Acute Ischemic Stroke Human Serum Albumin 20, 0.9 % Normal Saline - Cerebral Infarction | Phase 2 | Terminated | Seoul St. Mary's Hospital | 2 | 2012-09-01 | 2013-12-02 |
| Study of Human Placenta-derived Cells (PDA001) to Evaluate the Safety and Effectiveness for Patients With Ischemic Stroke Human Placenta-Derived Cells PDA001- (cenplacel-L), Placebo - Stroke, Acute, Middle Cerebral Artery Stroke | Phase 2 | Terminated | Celularity Incorporated | 44 | 2011-03-01 | 2018-03-01 |
| The Intravascular Cooling in the Treatment of Stroke 2/3 Trial hypothermia and anti-shivering treatment, Group1: IV t-PA and normothermia - Stroke, Acute | Phase 2 / Phase 3 | Terminated | University of California, San Diego | 120 | 2010-06-01 | 2017-04-05 |
| The Efficacy and Safety of MK0724 IV for Improvement of Neurological Damage and Recovery From Middle Cerebral Artery Ischemic Stroke (0724-018) Comparator: Placebo, Comparator: MK0724 - Middle Cerebral Artery Stroke | Phase 2 | Terminated | Merck Sharp & Dohme LLC | 150 | 2007-07-01 | 2015-07-22 |
Infarction, Middle Cerebral Artery (3) · Stroke (3) · Brain Diseases (2) · Cerebrovascular Disorders (2) · Ischemic Stroke (2) · Body Temperature Changes (1) · Brain Infarction (1) · Brain Ischemia (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Hypothermia (1) · Infarction, Posterior Cerebral Artery (1) · Nervous System Diseases (1) · Paresis (1)
Infarction (6) · Ischemia (6) · Necrosis (6) · Pathologic Processes (6) · Pathological Conditions, Signs and Symptoms (6) · Brain Infarction (5) · Brain Ischemia (5) · Cardiovascular Diseases (5) · Central Nervous System Diseases (5) · Nervous System Diseases (5) · Vascular Diseases (5) · Brain Diseases (4) · Cerebrovascular Disorders (4) · Cerebral Arterial Diseases (3)
Cool-Down Exercise (1) · Saline Solution (1) · Serum Albumin, Human (1) · basmisanil (1)
Celularity Incorporated (1) · Hoffmann-La Roche (1) · Merck Sharp & Dohme LLC (1) · ReNeuron Limited (1) · Seoul St. Mary's Hospital (1) · University of California, San Diego (1)
United States (3) · Austria (1) · France (1) · South Korea (1) · Spain (1) · Switzerland (1)
James C. Grotta, MD (1) · Kwang Soo Lee, M.D, Ph.D (1) · Monica E Luchi, MD (1) · Patrick D. Lyden, MD (1) · Richard Beckman, MD (1) · Thomas M. Hemmen, MD, PhD (1)
PMID 27834742, PMID 35130557, PMID 38419030, PMID 41541089
2015 (1), P50NS044148 (1), P50NS044227 (1)